HK1045464A1 - Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease - Google Patents

Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease

Info

Publication number
HK1045464A1
HK1045464A1 HK02107096A HK02107096A HK1045464A1 HK 1045464 A1 HK1045464 A1 HK 1045464A1 HK 02107096 A HK02107096 A HK 02107096A HK 02107096 A HK02107096 A HK 02107096A HK 1045464 A1 HK1045464 A1 HK 1045464A1
Authority
HK
Hong Kong
Prior art keywords
treatment
inflammatory bowel
bowel disease
prophylaxis
sulfodehydroabietic acid
Prior art date
Application number
HK02107096A
Other languages
English (en)
Inventor
Toru Kono
Masafumi Nomura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of HK1045464A1 publication Critical patent/HK1045464A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
HK02107096A 1999-11-11 2002-09-26 Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease HK1045464A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP32105899 1999-11-11
JP2000225442 2000-07-26
PCT/JP2000/007855 WO2001034143A1 (fr) 1999-11-11 2000-11-09 Agents de prevention ou de traitement de maladies inflammatoires de l'intestin

Publications (1)

Publication Number Publication Date
HK1045464A1 true HK1045464A1 (en) 2002-11-29

Family

ID=26570344

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107096A HK1045464A1 (en) 1999-11-11 2002-09-26 Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease

Country Status (17)

Country Link
US (3) US6730702B1 (de)
EP (1) EP1228758B1 (de)
KR (1) KR100526278B1 (de)
CN (1) CN100341497C (de)
AT (1) ATE366107T1 (de)
AU (1) AU773352B2 (de)
CA (1) CA2389032C (de)
CY (1) CY1106763T1 (de)
DE (1) DE60035429T2 (de)
DK (1) DK1228758T3 (de)
ES (1) ES2288878T3 (de)
HK (1) HK1045464A1 (de)
MX (1) MXPA02004707A (de)
NZ (1) NZ518695A (de)
PT (1) PT1228758E (de)
TW (1) TW585762B (de)
WO (1) WO2001034143A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases
NZ528937A (en) * 2001-04-17 2005-04-29 Tanabe Seiyaku Co The use of ecabet sodium for inflammatory disease in oral-cavity mucosa and the like
US6831101B2 (en) 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
MXPA04002868A (es) * 2001-09-27 2004-07-15 Tanabe Seiyaku Co Preparacion de solucion acuosa de ecabet sodico.
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
US8084432B2 (en) 2003-02-13 2011-12-27 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of pouchitis
CA2553775A1 (en) 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
KR100802192B1 (ko) * 2004-07-27 2008-02-11 이병수 한약재를 이용한 발모제 조성물
ES2621018T3 (es) 2007-02-19 2017-06-30 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
KR100963051B1 (ko) 2008-03-14 2010-06-09 광동제약 주식회사 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물
CN101590031B (zh) * 2008-06-17 2011-10-12 浙江爱生药业有限公司 磺化去氢松香酸二钠组合物的制备方法
MX342912B (es) 2010-04-15 2016-10-19 Marine Polymer Tech Inc Aplicaciones antibacterianas de nanofibras de poli-n-acetilglucosamina.
US20140127310A1 (en) * 2011-04-15 2014-05-08 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers
CN104447432B (zh) * 2014-11-21 2018-01-26 珠海亿邦制药股份有限公司 一种新的磺化去氢松香酸铋的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172690B1 (da) * 1981-10-22 1999-05-31 Tanabe Seiyaku Co Analogifremgangsmåde til fremstilling af salte af sulfodehydroabietinsyre eller hydrater deraf
GB2107584A (en) 1981-10-22 1983-05-05 Tanabe Seiyaku Co Treatment of gastro-intestinal diseases
JP3856908B2 (ja) 1997-06-06 2006-12-13 田辺製薬株式会社 褥瘡及び／又は創傷治療剤
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases

Also Published As

Publication number Publication date
ES2288878T3 (es) 2008-02-01
US6730702B1 (en) 2004-05-04
WO2001034143A1 (fr) 2001-05-17
AU1302501A (en) 2001-06-06
ATE366107T1 (de) 2007-07-15
US7153886B2 (en) 2006-12-26
PT1228758E (pt) 2007-08-24
TW585762B (en) 2004-05-01
EP1228758B1 (de) 2007-07-04
KR100526278B1 (ko) 2005-11-08
CA2389032A1 (en) 2001-05-17
US20040171686A1 (en) 2004-09-02
NZ518695A (en) 2003-10-31
KR20020050274A (ko) 2002-06-26
EP1228758A4 (de) 2004-04-21
US20040254244A1 (en) 2004-12-16
CN100341497C (zh) 2007-10-10
CN1414850A (zh) 2003-04-30
MXPA02004707A (es) 2002-09-02
CA2389032C (en) 2007-05-22
AU773352B2 (en) 2004-05-20
EP1228758A1 (de) 2002-08-07
DE60035429T2 (de) 2008-03-06
DE60035429D1 (de) 2007-08-16
CY1106763T1 (el) 2012-05-23
DK1228758T3 (da) 2007-10-29

Similar Documents

Publication Publication Date Title
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
ZA200104396B (en) Compositions and methods for stimulating gastrointestinal motility.
HK1045464A1 (en) Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease
ATE361077T1 (de) Indanylderivate zur behandlung von atemwegserkrankungen
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
SE9901573D0 (sv) New compounds
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
HUP0203716A2 (hu) Tumorellenes hatású szubsztituált (N-benzil-indol-3-il)-glioxilsav-származékok, ezeket tartalmazó gyógyszerkészítmények
IL150817A0 (en) Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
WO2000066550A8 (en) New compounds
MY160429A (en) 2, 5-disubstituted 3-mercaptopentanoic acid
CA2373962A1 (en) Immediate release medicinal compositions for oral use
MY133438A (en) Morpholinobenzamide salts
HRP20020238A2 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
EP2266566A3 (de) Nicotinamid Derivate und ihrer Verwendung als Therapeutika
SE0103272D0 (sv) Chemical compounds
IL143873A0 (en) Dry skin remedies
EP1413302A3 (de) Substitutierte Guanidinderivate zur Behandlung von Schmerz
WO2003035058A3 (en) Polymaleide compounds and their medical use
TH42244A (de)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161109